Cargando…
Hyaluronic acid–lipid binding
BACKGROUND: Phospholipid (PL)–hyaluronic acid (HA) interactions are relevant to aging-associated vitreous humor liquefaction, therapies for dry eye disease, skin-care products and synovial joint lubrication. Phosphatidyl choline–HA interactions have been well characterized. However, other major lipi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161914/ https://www.ncbi.nlm.nih.gov/pubmed/34044855 http://dx.doi.org/10.1186/s13065-021-00763-0 |
_version_ | 1783700606502830080 |
---|---|
author | Ewurum, Anthony Alur, Abhishek Ashok Glenn, Margaret Schnepf, Abigail Borchman, Douglas |
author_facet | Ewurum, Anthony Alur, Abhishek Ashok Glenn, Margaret Schnepf, Abigail Borchman, Douglas |
author_sort | Ewurum, Anthony |
collection | PubMed |
description | BACKGROUND: Phospholipid (PL)–hyaluronic acid (HA) interactions are relevant to aging-associated vitreous humor liquefaction, therapies for dry eye disease, skin-care products and synovial joint lubrication. Phosphatidyl choline–HA interactions have been well characterized. However, other major lipids found in tears, vitreous humor and synovial joints have not. The purpose of this study was to bridge this gap of knowledge. METHODS: HA (1600 kDa) at 5 mg/mL, was mixed with various lipids ranging in concentration from 0.1 to 10 mg/mL in D(2)O. HA–PL binding was measured from the decrease in HA proton resonance intensity with binding using a nuclear magnetic resonance spectrometer. RESULTS: Cholesterol weakly bound to HA, followed by monoglyceride and palmitoyl palmitate < phosphatidyl choline, phosphatidic acid and sphingomyelin. The maximum amount of PL bound was 14 ± 1 µmoles inferring a 1 to 1 molar ratio of bound PL to HA dimer. Monoglyceride and palmitoyl palmitate required two to three times more lipid to achieve 100% bound HA compared to PL. CONCLUSIONS: Physiological levels of HA, phosphatidyl choline and sphingomyelin would result in only 4% of the hydrophobic hydrogens of HA to be bound. HA–PL binding interactions could be important for therapeutic use of HA in eye drops in future studies to treat dry eye and to trap PL entering the VH to keep them from forming light scattering micelles. HA–lipid binding may also be relevant to the therapeutic effects of topical skin-care products. Both head group and hydrocarbon chain moieties influence HA–lipid interactions. |
format | Online Article Text |
id | pubmed-8161914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-81619142021-06-01 Hyaluronic acid–lipid binding Ewurum, Anthony Alur, Abhishek Ashok Glenn, Margaret Schnepf, Abigail Borchman, Douglas BMC Chem Research Article BACKGROUND: Phospholipid (PL)–hyaluronic acid (HA) interactions are relevant to aging-associated vitreous humor liquefaction, therapies for dry eye disease, skin-care products and synovial joint lubrication. Phosphatidyl choline–HA interactions have been well characterized. However, other major lipids found in tears, vitreous humor and synovial joints have not. The purpose of this study was to bridge this gap of knowledge. METHODS: HA (1600 kDa) at 5 mg/mL, was mixed with various lipids ranging in concentration from 0.1 to 10 mg/mL in D(2)O. HA–PL binding was measured from the decrease in HA proton resonance intensity with binding using a nuclear magnetic resonance spectrometer. RESULTS: Cholesterol weakly bound to HA, followed by monoglyceride and palmitoyl palmitate < phosphatidyl choline, phosphatidic acid and sphingomyelin. The maximum amount of PL bound was 14 ± 1 µmoles inferring a 1 to 1 molar ratio of bound PL to HA dimer. Monoglyceride and palmitoyl palmitate required two to three times more lipid to achieve 100% bound HA compared to PL. CONCLUSIONS: Physiological levels of HA, phosphatidyl choline and sphingomyelin would result in only 4% of the hydrophobic hydrogens of HA to be bound. HA–PL binding interactions could be important for therapeutic use of HA in eye drops in future studies to treat dry eye and to trap PL entering the VH to keep them from forming light scattering micelles. HA–lipid binding may also be relevant to the therapeutic effects of topical skin-care products. Both head group and hydrocarbon chain moieties influence HA–lipid interactions. Springer International Publishing 2021-05-27 /pmc/articles/PMC8161914/ /pubmed/34044855 http://dx.doi.org/10.1186/s13065-021-00763-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Ewurum, Anthony Alur, Abhishek Ashok Glenn, Margaret Schnepf, Abigail Borchman, Douglas Hyaluronic acid–lipid binding |
title | Hyaluronic acid–lipid binding |
title_full | Hyaluronic acid–lipid binding |
title_fullStr | Hyaluronic acid–lipid binding |
title_full_unstemmed | Hyaluronic acid–lipid binding |
title_short | Hyaluronic acid–lipid binding |
title_sort | hyaluronic acid–lipid binding |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161914/ https://www.ncbi.nlm.nih.gov/pubmed/34044855 http://dx.doi.org/10.1186/s13065-021-00763-0 |
work_keys_str_mv | AT ewurumanthony hyaluronicacidlipidbinding AT alurabhishekashok hyaluronicacidlipidbinding AT glennmargaret hyaluronicacidlipidbinding AT schnepfabigail hyaluronicacidlipidbinding AT borchmandouglas hyaluronicacidlipidbinding |